Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

Clinical trial NCT03571633 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03571633
Sponsor: Centre Leon Berard
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Operable Breast Cancer

Start date: 2018-08-06
Primary completion: 2027-01-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.